论文信息 - Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009 - 字舞流文

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009

K. Ruxrungtham | D. Cooper | P. Phanuphak | C. Duncombe | P. Phanuphak | U. Siangphoe | M. Boyd | J. Lange | M. Stek | J. Lange | D. Cooper | M. Boyd | CJ Duncombe | CJ Duncombe | Mark A. Boyd | C. J. Duncombe | Michael Stek | J. M. A. Lange | David A. Cooper | J. M. Lange | C. Duncombe